|
gptkbp:instanceOf
|
gptkb:chemical_compound
|
|
gptkbp:ATCCode
|
none
|
|
gptkbp:canBe
|
treatment of growth hormone deficiency
treatment of osteoporosis
treatment of obesity
treatment of muscle wasting
treatment of frailty in elderly
|
|
gptkbp:CASNumber
|
gptkb:193275-84-2
|
|
gptkbp:clinicalTrialPhase
|
Phase II
|
|
gptkbp:developedBy
|
gptkb:Merck_&_Co.
|
|
gptkbp:drugClass
|
recombinant human growth hormone
ghrelin receptor agonist
|
|
gptkbp:effect
|
increases IGF-1 levels
stimulates appetite
increases growth hormone levels
increases lean body mass
|
|
gptkbp:hasInChIKey
|
QZJTYWYYFZJCFI-UHFFFAOYSA-N
|
|
gptkbp:hasMolecularFormula
|
C27H36N4O5S
|
|
gptkbp:hasSMILES
|
CC(C)CN(C)CCCN=C(N)NCC1=CC=CC=C1C(=O)NC2=CC=CC=C2S(=O)(=O)C
|
|
gptkbp:hasUNII
|
QX8X9N6F2H
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
193275-84-2
|
|
gptkbp:isNotApprovedForMedicalUse
|
true
|
|
gptkbp:legalStatus
|
investigational
|
|
gptkbp:molecularWeight
|
528.7 g/mol
|
|
gptkbp:otherName
|
gptkb:Ibutamoren
gptkb:MK-677
|
|
gptkbp:PubChem_CID
|
gptkb:CHEMBL121412
159633
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:synonym
|
L-163,191
|
|
gptkbp:bfsParent
|
gptkb:lonafarnib
|
|
gptkbp:bfsLayer
|
7
|